Skip to content
Review

Modulating Stress Granules via HDAC6 Inhibition: A Promising Strategy against Alzheimer's Disease.

Jul 2026 · ACS Chemical Neuroscience · Vol 17, pp. 2771-2774 · 0 citations · 18 references
Medicine

TL;DR

The current understanding of HDAC6-mediated SG regulation in AD is highlighted, critical knowledge gaps are identified, and the therapeutic potential of selective HDAC6 inhibition in modulating SG pathology and neuroinflammation is discussed.

Abstract

Emerging evidence suggests that dysregulated cellular stress responses, particularly the formation and persistence of stress granules (SGs), may significantly contribute to Alzheimer's disease (AD) pathogenesis. SGs are dynamic, membrane-less ribonucleoprotein assemblies that sequester stalled translation preinitiation complexes during cellular stress. Under physiological conditions, SGs are transient and disassemble upon stress resolution, often facilitated by heat shock proteins (HSPs). However, under chronic stress, persistent or aberrant SGs can form, which may seed pathological protein aggregation and exacerbate proteostatic imbalance, neuroinflammation, and neurodegeneration. Despite the growing body of evidence linking HDAC6 to SG dynamics and AD pathology, the precise mechanistic relationship remains unresolved. This review highlights the current understanding of HDAC6-mediated SG regulation in AD, identifies critical knowledge gaps, and discusses the therapeutic potential of selective HDAC6 inhibition in modulating SG pathology and neuroinflammation.

View source

Similar papers

Review Open access Sep 2026

The Paradox of Tau and RNA-Binding Proteins: How Adaptive Stress Granule Regulation Becomes Pathological with Aging

Reducing biomolecular condensates in stress and disease could provide a general effective therapeutic approach for multiple neurodegenerative diseases, according to specific pathways being pursued for reducing levels of stress granules, aggregated RNA binding proteins and oligomeric Tau.

Benjamin Wolozin, Merci N. Best, Madhav Ellini et al. · 0 citations
Review Aug 2026

Polysaccharides targeting organelle network dysfunction in Alzheimer's disease: A review.

Alzheimer's disease (AD) is driven by an interrelated pathological network, which to some extent explains the limited efficacy of single-target therapies and constitutes a significant challenge in current clinical treatment. Emerging evidence indicates that dysfunction and crosstalk among mitochondria, the endoplasmic...

Xin-Yi Yu, Pei Gao, Qiaoling Yao et al. · 0 citations
Review Open access Sep 2026

Orchestrating Stress Granule Dynamics by SUMOylation: A New Frontier in Treating Stress-Induced Age-Related Diseases.

Stress granules (SGs), membrane-less organelles formed via liquid-liquid phase separation (LLPS), function as essential adaptive compartments that sequester mRNAs and proteins during acute stress. However, during chronic stress or aging, these dynamic condensates can undergo an irreversible phase transition into pathol...

Jia-Cheng Zhang, Han Hu, Yu-Tian Zhu et al. · 0 citations
Review Open access Sep 2026

PERK signalling in neurodegenerative diseases: From ER stress to mitochondrial dysfunction and therapeutic opportunities

The activation mechanisms of the PERK pathway in diseases such as Alzheimer’s disease and Parkinson’s disease are reviewed, focusing on its role as a molecular bridge that converts endoplasmic reticulum stress into mitochondrial dysfunction.

Tao Xu, Sheng-Wei Jing, Jing Wu · 0 citations
Open access Aug 2026

FMRP modulates stress granule remodelling in cancer cells via G3BP1

Findings support a role for FMRP as a regulator of SG dynamics and identify the FMRP–G3BP1 axis as a candidate pathway for further investigation in aggressive and treatment-resistant cancers and in tumor adaptation to oxidative stress across distinct cellular contexts and survival programs.

Elena Santonico, Federica Ferrentino, C. Cirotti et al. · 0 citations
Review Open access Sep 2026

Advances in phytochemical modulation of protein aggregation in neurodegenerative diseases

Overall, the accumulated evidence indicates that phytochemicals possess multitarget therapeutic potential by simultaneously reducing protein aggregation, oxidative stress, mitochondrial dysfunction, and neuroinflammation, thereby offering broader neuroprotection than single-target approaches.

Nitu Kumari, Santosh Anand · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.